How Does Mounjaro Work — and What Side Effects Should You Know About?

How does tirzepatide actually reduce appetite?

Most weight-loss medicines work through one gut-hormone pathway. Tirzepatide works through two. It activates both the GLP-1 (glucagon-like peptide-1) receptor and the GIP (glucose-dependent insulinotropic polypeptide) receptor, the combination is why Mounjaro is sometimes described as a dual agonist, and it is the only medicine of its kind licensed in the UK for weight management.

GLP-1 activation slows gastric emptying, so food sits in your stomach longer and fullness signals reach your brain sooner. GIP activation works alongside this, influencing fat storage and further blunting the drive to eat. The net result for most people is a meaningful reduction in hunger between meals and a lower natural stopping point during them. The NHS medicines page for tirzepatide explains the mechanism in plain terms and is a useful first reference.

Mounjaro is given as a once-weekly injection from a pre-filled KwikPen. Treatment starts at 2.5mg (a dose whose job is to let your body adjust, not to deliver the full therapeutic effect) and a prescriber steps the dose up over several months. Exploring what weight-loss treatment with Mounjaro involves is a good starting point if you want the fuller picture before booking a consultation.

What side effects does Mounjaro most commonly cause?

The side-effect profile is dominated by the gut, and that is almost entirely explained by the gastric-slowing mechanism. When digestion slows, the digestive system takes time to adapt. Nausea is the most frequently reported symptom, followed by loose stools or diarrhoea, constipation, indigestion, reflux, and burping. Fatigue, headache and dizziness also appear in clinical data, more often around dose changes than at a stable dose.

For most people these effects are mild to moderate and settle within a week or two of starting each new dose. Eating smaller portions, choosing lower-fat foods, and staying well hydrated all tend to help. Our prescribers discuss practical strategies as part of the clinical consultation, you are not left to figure it out alone.

A fuller breakdown of the complete side-effect list from the prescribing information is covered on our Mounjaro side effects page, and if you want to know how long these effects typically last, the answer varies by symptom but the pattern is consistent across clinical trial data.

Injection-site reactions (mild redness or discomfort at the spot you inject) are also reported. Rotating between the abdomen, thigh, and upper arm keeps any one site from becoming irritated.

When does a side effect need urgent medical attention?

This is the section worth reading carefully. Most symptoms are uncomfortable rather than dangerous, but some require prompt action.

In January 2026 the MHRA issued a Drug Safety Update confirming that acute pancreatitis (inflammation of the pancreas) is a known, if uncommon, risk with GLP-1 medicines including tirzepatide. The symptom to recognise is severe, persistent stomach pain that radiates to the back, sometimes with vomiting. If you experience that, stop the injection and seek urgent medical help. Do not wait to see whether it passes.

Other symptoms that need same-day or emergency attention include: signs of a serious allergic reaction (swelling of the face, throat or tongue; difficulty breathing; rapid heartbeat); symptoms of severe dehydration after prolonged vomiting or diarrhoea (very dark urine, confusion, dizziness that does not settle); and gallbladder pain, typically a sharp pain in the upper right abdomen, sometimes radiating to the right shoulder.

If you notice mood changes, low mood, or thoughts of self-harm, tell a healthcare professional promptly. It is listed in the prescribing information and worth taking seriously. The MHRA's Yellow Card scheme exists so that patients and carers can report any suspected side effect, your report contributes to ongoing safety monitoring for all medicines. If you have specific questions about your own symptoms, our aftercare team is available seven days a week.

Are there people for whom Mounjaro's side effects carry extra risk?

Clinical suitability is always assessed individually, but a few situations carry documented caution. A personal or family history of medullary thyroid carcinoma or MEN2 syndrome is a contraindication. A history of pancreatitis means a prescriber will look carefully before recommending tirzepatide. Certain gastrointestinal conditions (including gastroparesis) may make the gastric-slowing effect problematic.

Tirzepatide is not licensed for use during pregnancy or breastfeeding, and it is not recommended for anyone trying to conceive. It is not licensed for under-18s. Women taking the oral contraceptive pill should be aware that for the first four weeks of treatment, and for four weeks after each dose increase, absorption of the pill may be reduced, an additional contraceptive method is advisable during those windows, per NHS guidance.

If you are taking other medicines, a prescriber will review for interactions; the BNF entry for tirzepatide is where clinical teams check interaction data. On the five most commonly asked-about Mounjaro side effects, we go deeper on each one, practical management, how long they tend to last, and what the trial data actually shows. For guidance on reducing the likelihood of side effects from the start, our page on managing Mounjaro side effects covers the evidence-based approaches our prescribers recommend. If you would like a thorough overview before starting, our dedicated page covering what side effects Mounjaro can cause brings together the full picture in one place. A consultation through nume's free clinical consultation is where suitability and your individual risk profile are discussed in full, by a real prescriber, not an automated questionnaire.